Coxsackievirus A21 utilizes DAF as a low-affinity attachment receptor to enhance viral presentation or sequestration for subsequent high-affinity binding to ICAM-1 for cell entry.
Authors
No takes yet. Share an insight, caveat, or question.
Should not yet change clinical management of coxsackievirus infections; hypothesis-generating for dual-receptor targeting in future studies.
Shafren et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: